Home/Filings/5/0001387131-22-001717
5//SEC Filing

SAENGER BRADLEY 5

Accession 0001387131-22-001717

CIK 0001430306other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:18 PM ET

Size

4.9 KB

Accession

0001387131-22-001717

Insider Transaction Report

Form 5
Period: 2021-12-31
SAENGER BRADLEY
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2021-06-30$0.58/sh+18,248$10,58419,645 total
Footnotes (1)
  • [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001668150

Filing Metadata

Form type
5
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:18 PM ET
Size
4.9 KB